Get all company financials in excel:

Download Sample   $19.99

More Charts

Gedeon Richter Plc. (Richter) is a Hungary-based company specializing in the research, development, production and marketing of pharmaceutical products. The Company focuses in both retail and wholesale market of pharmaceutical products. Its pharmaceutical product range covers therapeutic areas such as cardiovascular, gastrointestinal, gynecology, muscle relaxants, central nervous system and others. Richter has a direct presence in 30 countries with a total of four manufacturing facilities, 14 commercial subsidiaries and wholesalers and 30 representative offices. It sells its pharmaceutical products through its own distribution network to over 100 countries all over the world. Gedeon Richter is headquartered in Budapest, Hungary.

Finance

Gedeon Richter has been growing its sales by a year on average in the last 5 years. EBITDA has grown on average by 3.34% a year during that time to total of HUF 98,759 mil in 2015, or 27.0% of sales. That’s compared to 23.6% average margin seen in last five years.

The company netted HUF 54,277 mil in 2015 implying ROE of 9.18% and ROCE of 9.77%. Again, the average figures were 8.41% and 8.52%, respectively when looking at the previous 5 years.

Gedeon Richter’s net debt amounted to HUF -88,663 mil at the end of 2015, or -0.143 of equity. When compared to EBITDA, net debt was -0.898x, down when compared to average of -0.628x seen in the last 5 years.

Valuation

Gedeon Richter stock traded at HUF 5,498 per share at the end of 2015 resulting in a market capitalization of USD 3,920 mil. Over the previous five years, stock price grew by 29.2% or 5.26% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 8.65x and price to earnings (PE) of 18.9x as of 2015.